BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22972594)

  • 21. Atypical mucocutaneous involvement with Leishmania donovani.
    Pulimood SA; Rupali P; Ajjampur SS; Thomas M; Mehrotra S; Sundar S
    Natl Med J India; 2012; 25(3):148-50. PubMed ID: 22963292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First case of indigenous visceral leishmaniasis from central India.
    Dey A; Sharma U; Singh S
    Am J Trop Med Hyg; 2007 Jul; 77(1):95-8. PubMed ID: 17620636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Visceral leishmaniasis refractory to treatment: the efficacy of amphotericin B].
    Pérez Brea A; Ruiz Moreno M; Leal Orozco A; Escorihuela Esteban R; Otero Fraguas M
    An Esp Pediatr; 1996 Feb; 44(2):161-3. PubMed ID: 8830578
    [No Abstract]   [Full Text] [Related]  

  • 24. Isolated laryngeal leishmaniasis in an immunocompetent patient: a case report.
    Tiseo D; Tosone G; Conte MC; Scordino F; Mansueto G; Mesolella M; Parrella G; Pennone R; Orlando R
    Infez Med; 2008 Dec; 16(4):233-5. PubMed ID: 19155691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diarrhea due to visceral leishmaniasis in a liver transplant recipient].
    Vargas Acosta AM; Belchí Segura E; Martinez Caselles A; Baños Madrid R; Pons Miñano JA; Parrilla Paricio P
    Gastroenterol Hepatol; 2013 Apr; 36(4):271-3. PubMed ID: 23453560
    [No Abstract]   [Full Text] [Related]  

  • 26. Chronic diarrhea and malabsorption caused by Leishmania donovani.
    Baba CS; Makharia GK; Mathur P; Ray R; Gupta SD; Samantaray JC
    Indian J Gastroenterol; 2006; 25(6):309-10. PubMed ID: 17264434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laryngeal leishmaniasis in Malta.
    Fsadni C; Fsadni P; Piscopo T; Mallia Azzopardi C
    J Infect; 2007 Feb; 54(2):e61-3. PubMed ID: 16797076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonmigrant children with visceral leishmaniasis from the nonendemic area of Uttarakhand.
    Mathur SB; Arya AK
    J Trop Pediatr; 2014 Aug; 60(4):322-5. PubMed ID: 24531375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unusual case of resistance to amphotericin B in visceral leishmaniasis in a region in India where leishmaniasis is not endemic.
    Srivastava P; Prajapati VK; Rai M; Sundar S
    J Clin Microbiol; 2011 Aug; 49(8):3088-91. PubMed ID: 21613432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimony-induced cerebellar ataxia.
    Khalil EA; Ahmed AE; Musa AM; Hussein MH
    Saudi Med J; 2006 Jan; 27(1):90-2. PubMed ID: 16432602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing pattern of visceral leishmaniasis, United Kingdom, 1985-2004.
    Malik AN; John L; Bruceson AD; Lockwood DN
    Emerg Infect Dis; 2006 Aug; 12(8):1257-9. PubMed ID: 16965709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of visceral leishmaniasis with liposomal amphotericin B.
    Lagler H; Matt U; Sillaber C; Winkler S; Graninger W
    Acta Biomed; 2006; 77 Suppl 2():22-5. PubMed ID: 16918063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphotericin B inhibits entry of Leishmania donovani into primary macrophages.
    Paila YD; Saha B; Chattopadhyay A
    Biochem Biophys Res Commun; 2010 Aug; 399(3):429-33. PubMed ID: 20678487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic PCR with Leishmania donovani specificity using sequences from the variable region of kinetoplast minicircle DNA.
    Singh N; Curran MD; Rastogil AK; Middleton D; Sundar S
    Trop Med Int Health; 1999 Jun; 4(6):448-53. PubMed ID: 10444321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visceral leishmaniasis in a lung transplant recipient: usefulness of highly sensitive real-time polymerase chain reaction for preemptive diagnosis.
    Opota O; Balmpouzis Z; Berutto C; Kaiser-Guignard J; Greub G; Aubert JD; Prod'hom G; Manuel O; Jaton K
    Transpl Infect Dis; 2016 Oct; 18(5):801-804. PubMed ID: 27495987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Liposomal amphotericin B as treatment for visceral leishmaniasis in Europe, 2009].
    Rosenthal E; Delaunay P; Jeandel PY; Haas H; Pomares-Estran C; Marty P
    Med Mal Infect; 2009 Oct; 39(10):741-4. PubMed ID: 19783391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Visceral leishmaniasis: not only a tropical disease].
    Cuperus FJ; Oosterwijk PR; Vos A; Remijn JA; van Dobbenburgh A; Bisseling TM
    Ned Tijdschr Geneeskd; 2013; 157(27):A5958. PubMed ID: 23838400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Periodic fever and pancytopenia in a 35-year-old patient].
    Schmutz M; Schaller T; Kubuschok B; Fleischmann C; Hirschbühl K; Dintner S; Häckel T; Märkl B; Trepel M; Claus R
    Internist (Berl); 2019 Dec; 60(12):1305-1310. PubMed ID: 31549186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visceral leishmaniasis and Coombs' positive hemolytic anemia: a rare association in an infant treated with liposomal amphotericin B.
    Dilber E; Erduran E; Işik Y
    Turk J Pediatr; 2002; 44(4):354-6. PubMed ID: 12458816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laryngeal leishmaniasis in a patient taking inhaled corticosteroids.
    Roberts RM; Mukherjee J; Phillips D
    BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27329097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.